The Role of Butylidenephthalide in Targeting the Microenvironment Which Contributes to Liver Fibrosis Amelioration

The treatment of liver fibrosis has clinical limitations because of its multiple etiologies, such as epithelial–mesenchymal transition (EMT) promotion, cell regeneration and remodeling dysfunction, inflammatory cell activation, and scar tissue deposition. These factors might be considered as a new t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Chuang, Hong-Meng, Su, Hong-Lin, Li, Chien, Lin, Shinn-Zong, Yen, Ssu-Yin, Huang, Mao-Hsuan, Ho, Li-Ing, Chiou, Tzyy-Wen, Harn, Horng-Jyh
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2016
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847481/
https://ncbi.nlm.nih.gov/pubmed/27199755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00112
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars